PL1799231T3 - Zastosowanie cyklodekstryny do leczenia i zapobiegania chorobom zapalnym oskrzeli - Google Patents
Zastosowanie cyklodekstryny do leczenia i zapobiegania chorobom zapalnym oskrzeliInfo
- Publication number
- PL1799231T3 PL1799231T3 PL05801277T PL05801277T PL1799231T3 PL 1799231 T3 PL1799231 T3 PL 1799231T3 PL 05801277 T PL05801277 T PL 05801277T PL 05801277 T PL05801277 T PL 05801277T PL 1799231 T3 PL1799231 T3 PL 1799231T3
- Authority
- PL
- Poland
- Prior art keywords
- prevention
- treatment
- inflammatory diseases
- cyclodextrin
- bronchial inflammatory
- Prior art date
Links
- 229920000858 Cyclodextrin Polymers 0.000 title abstract 2
- 208000027866 inflammatory disease Diseases 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 title 1
- -1 cyclodextrin compound Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04104957A EP1655034A1 (en) | 2004-10-10 | 2004-10-10 | Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases. |
| EP05801277A EP1799231B1 (en) | 2004-10-10 | 2005-09-30 | Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases |
| PCT/EP2005/054966 WO2006037769A1 (en) | 2004-10-10 | 2005-09-30 | Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1799231T3 true PL1799231T3 (pl) | 2010-07-30 |
Family
ID=34929683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05801277T PL1799231T3 (pl) | 2004-10-10 | 2005-09-30 | Zastosowanie cyklodekstryny do leczenia i zapobiegania chorobom zapalnym oskrzeli |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US7829550B2 (pl) |
| EP (2) | EP1655034A1 (pl) |
| JP (1) | JP4989481B2 (pl) |
| AT (1) | ATE456955T1 (pl) |
| DE (1) | DE602005019247D1 (pl) |
| ES (1) | ES2340511T3 (pl) |
| PL (1) | PL1799231T3 (pl) |
| WO (1) | WO2006037769A1 (pl) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9545424B2 (en) | 2007-06-01 | 2017-01-17 | SolAero Med Inc. | Method of treating pulmonary surfactant dysfunction or respiratory distress syndrome by administering cyclodextrin or a derivative thereof |
| EP2600864B1 (en) * | 2010-08-04 | 2019-01-09 | University Of Virginia Patent Foundation | Compositions and methods for treating inflammatory diseases |
| CN107865968B (zh) | 2012-08-03 | 2021-03-05 | 美国政府(由卫生和人类服务部的部长所代表) | 用于治疗溶酶体贮积症的环糊精 |
| RU2506080C1 (ru) * | 2012-09-25 | 2014-02-10 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия" Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО НижГМА Минздравсоцразвития России) | Способ лечения и профилактики осложнений в полости рта, вызванных приемом ингаляционных гормональных препаратов у больных бронхиальной астмой |
| JP6181188B2 (ja) * | 2012-09-27 | 2017-08-16 | ソールエアロメッド インク． | コレステロール捕捉シクロデキストリンを用いた肺表面活性物質機能障害の治療 |
| FR3014694B1 (fr) | 2013-12-13 | 2016-11-11 | Roquette Freres | Compositions a base de methyl-cyclodextrines pour le traitement et/ou la prevention de maladies par augmentation du taux de cholesterol-hdl |
| NZ724902A (en) * | 2014-03-28 | 2023-03-31 | Univ Liege | Composition comprising cyclodextrin and budesonide derivatives for the treatment and prophylaxis of pulmonary inflammations |
| EP2923702A1 (en) * | 2014-03-28 | 2015-09-30 | Universite De Liege | Composition of cyclodextrin with budesonide derivatives for treatment and prevention of pulmonary inflammatory disease |
| EP3307278A4 (en) | 2015-06-10 | 2018-06-13 | Vtesse, Inc. | Hydroxypropyl beta-cyclodextrin compositions and methods |
| CN112334494A (zh) | 2018-06-29 | 2021-02-05 | 罗盖特公司 | 新颖的羟丙基-β-环糊精及其生产方法 |
| FR3083234B1 (fr) * | 2018-06-29 | 2020-11-27 | Roquette Freres | Nouvelles hydroxypropyl-beta-cyclodextrines et leurs procedes de preparation |
| BE1027425B1 (fr) * | 2019-07-01 | 2021-02-08 | Aquilon Pharmaceuticals | Composition inhalable comprenant de la cyclodextrine a utiliser dans le traitement d’inflammations nasales |
| BE1027612B1 (fr) | 2019-09-10 | 2021-05-03 | Aquilon Pharmaceuticals | Microparticules en forme de balle de golf pour une utilisation dans le traitement et la prevention de maladies pulmonaires |
| US11045434B1 (en) | 2020-04-01 | 2021-06-29 | UNION therapeutics A/S | Niclosamide formulations for treating disease |
| MA53516A1 (fr) * | 2020-06-15 | 2022-04-29 | Univ Liege | Cyclodextrine utilisée dans le traitement et la prévention de la bronchoconstriction en phase tardive de l'asthme provoqué par des allergènes. |
| WO2023118014A1 (en) | 2021-12-20 | 2023-06-29 | Aquilon Pharmaceuticals | Inhalable compositions comprising a complex of hpbcd and budesonide or ciclesonide for the treatment or prevention of a respiratory viral disease or lipopolysaccharide-induced inflammation, in particular lipopolysaccharide-induced inflammation associated with a respiratory viral disease |
| BE1030002B1 (fr) | 2021-12-29 | 2023-09-01 | Aquilon Pharmaceuticals | Compositions inhalables comprenant un complexe de hpbcd et de budesonide ou ciclesonide pour le traitement ou la prevention d'une maladie virale respiratoire |
| KR20240160120A (ko) | 2022-02-18 | 2024-11-08 | 베렌 테라퓨틱스 피.비.씨. | 하이드록시프로필-베타-사이클로덱스트린의 조성물 및 이의 정제 방법 |
| BE1031693B1 (fr) | 2023-06-07 | 2025-01-23 | Aquilon Pharmaceuticals | Compositions sans conservateur comprenant un complexe de corticostéroïde et d'hpbcd pour le traitement ou la prévention d'une maladie inflammatoire par administration nasale |
| WO2024251923A1 (en) | 2023-06-07 | 2024-12-12 | Aquilon Pharmaceuticals | Preservative-free compositions comprising a complex of a corticosteroid and hpbcd for the treatment or prevention of an inflammatory disease through nasal administration |
| BE1031691B1 (fr) | 2023-06-07 | 2025-01-23 | Aquilon Pharmaceuticals | Compositions sans conservateur comprenant un complexe de corticostéroïde et d'hpbcd pour le traitement ou la prévention d'une maladie inflammatoire par administration nasale |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4054736A (en) * | 1970-06-10 | 1977-10-18 | Ono Pharmaceutical Co., Ltd. | Clathrate compounds of prostaglandins or their analogues with cyclodextrin |
| JPS62123132A (ja) * | 1985-11-21 | 1987-06-04 | Michio Nakanishi | 気管支喘息治療用組成物 |
| JPS62292719A (ja) * | 1986-06-12 | 1987-12-19 | Kaken Pharmaceut Co Ltd | 外用澄明水溶性製剤 |
| US5254541A (en) * | 1991-11-15 | 1993-10-19 | Merck Frosst Canada, Inc. | (Quinolin-2-ylmethoxy)indole/cyclodextrin complex |
| US5840713A (en) * | 1995-04-03 | 1998-11-24 | Weisz; Paul B. | Therapy for tissue membrane insufficiency |
| AU4717997A (en) * | 1996-10-28 | 1998-05-22 | Farmarc Nederland Bv | Inclusion complexes of beta-2-andrenergics for oral mucosal delivery |
| JP2006008568A (ja) * | 2004-06-24 | 2006-01-12 | Cyclochem:Kk | ＩｇＥ抗体抑制剤および食品 |
-
2004
- 2004-10-10 EP EP04104957A patent/EP1655034A1/en not_active Withdrawn
-
2005
- 2005-09-30 WO PCT/EP2005/054966 patent/WO2006037769A1/en not_active Ceased
- 2005-09-30 PL PL05801277T patent/PL1799231T3/pl unknown
- 2005-09-30 JP JP2007535148A patent/JP4989481B2/ja not_active Expired - Fee Related
- 2005-09-30 US US11/664,999 patent/US7829550B2/en active Active
- 2005-09-30 EP EP05801277A patent/EP1799231B1/en not_active Expired - Lifetime
- 2005-09-30 ES ES05801277T patent/ES2340511T3/es not_active Expired - Lifetime
- 2005-09-30 AT AT05801277T patent/ATE456955T1/de active
- 2005-09-30 DE DE602005019247T patent/DE602005019247D1/de not_active Expired - Lifetime
-
2010
- 2010-07-29 US US12/846,241 patent/US20110028432A1/en not_active Abandoned
-
2012
- 2012-05-23 US US13/478,743 patent/US20120295872A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20120295872A1 (en) | 2012-11-22 |
| EP1799231B1 (en) | 2010-02-03 |
| JP2008515847A (ja) | 2008-05-15 |
| US7829550B2 (en) | 2010-11-09 |
| US20110028432A1 (en) | 2011-02-03 |
| EP1655034A1 (en) | 2006-05-10 |
| ES2340511T3 (es) | 2010-06-04 |
| DE602005019247D1 (de) | 2010-03-25 |
| JP4989481B2 (ja) | 2012-08-01 |
| EP1799231A1 (en) | 2007-06-27 |
| US20090012041A1 (en) | 2009-01-08 |
| ATE456955T1 (de) | 2010-02-15 |
| WO2006037769A1 (en) | 2006-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200703601B (en) | Medicaments for the treatment or prevention of fibriotic diseases | |
| DE602005019247D1 (de) | Verwendung von cyclodextrin zur behandlung und vorbeugung von entzündlichen bronchialerkrankungen | |
| WO2006119295A3 (en) | Compositions and methods for the treatment of neurodegenerative diseases | |
| WO2006120176A3 (en) | Combination of the pde4 inhibitor roflumilast and a tetrahydrobiopterin derivative | |
| ZA200804742B (en) | Compounds for the treatment of inflammatory disorders and microbial diseases | |
| IL191637A0 (en) | Compounds for the treatment of inflammatory disorders and microbial diseases | |
| HUS1500058I1 (hu) | Benzoxazint tartalmazó gyógyszer-kombináció légúti betegségek kezelésére | |
| ATE534391T1 (de) | 3,11b-cis-dihydrotetrabenazin zur behandlung von psychosen | |
| IL184124A0 (en) | Medicaments for the treatment or prevention of fibrotic diseases | |
| LTC2805723I2 (lt) | Kladribino režimas, skirtas išsėtinei sklerozei gydyti | |
| WO2005085266A3 (en) | Macrocyclic compounds and methods of making and using the same | |
| ZA200801171B (en) | 3, IIB-CIS-dihydrotetrabenazine for the treatment of a proliferative disease or an inflammation | |
| ZA200800981B (en) | Use of SDF-1 for the treatment and/or prevention of neurological diseases | |
| UA88655C2 (ru) | S-миртазапин для лечения прилива крови | |
| WO2005118610A3 (en) | Macrocyclic compounds and methods of making and using the same | |
| IL182008A (en) | Use of an antithrombotic compound for the manufacture of a medicament for pulmonary delivery for prevention or treatment of thrombosis or related disorders | |
| WO2007054566A3 (en) | Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy | |
| WO2008112701A3 (en) | G-substrate for the treatment and prevention of parkinson's disease | |
| IL190842A0 (en) | Use of sdf-1 for the treatment and/or prevention of neurological diseases | |
| AU2004903986A0 (en) | Compounds for the Treatment of Vascular Diseases | |
| HK1124041A (en) | Compounds for the treatment of inflammatory disorders and microbial diseases | |
| HK1123490A (en) | Compounds for the treatment of inflammatory disorders and microbial diseases | |
| AU2005900589A0 (en) | Soy-derived products for the treatment of vascular diseases | |
| UA87224C2 (ru) | Применение 24-нор-урсодеоксихолевой кислоты для лечения холестатических заболеваний печени |